Detailed answers about DOCTOR KING & COMPANY LIMITED, including incorporation, status, business activity, and accounts information.
When was DOCTOR KING & COMPANY LIMITED founded?
DOCTOR KING & COMPANY LIMITED was officially incorporated on 6 September 2012 and is registered under company number 08204981. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DOCTOR KING & COMPANY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DOCTOR KING & COMPANY LIMITED?
DOCTOR KING & COMPANY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DOCTOR KING & COMPANY LIMITED do?
DOCTOR KING & COMPANY LIMITED operates in the following sectors: 14190 - Manufacture of other wearing apparel and accessories n.e.c., 25990 - Manufacture of other fabricated metal products n.e.c., 26400 - Manufacture of consumer electronics, 47910 - Retail sale via mail order houses or via Internet. These SIC codes provide insight into the company's business activities and industry focus.
What is DOCTOR KING & COMPANY LIMITED's registered address?
The registered office address of DOCTOR KING & COMPANY LIMITED is 71-75 SHELTON STREET, COVENT GARDEN, LONDON, ENGLAND, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is DOCTOR KING & COMPANY LIMITED financially stable?
The most recent accounts for DOCTOR KING & COMPANY LIMITED were made up to 30 September 2024, filed as MICRO ENTITY. Next accounts are due by 30 June 2026.